USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF SPASTICITY IN CHILDREN WITH CEREBRAL PALSY: Lazić L et al.

Cerebral palsy has an incidence of about 1-2 per 1000 live births, and in spite of the progress of neonatal medicine, it seems that the incidence will not subside in the near future. …

Review article UDC: 616.831-009.11-085.371-053.2doi:10.5633/amm.2011.0212
Acta Medica Medianae2011;50(2):63-67
 
Autoren:
Ljiljana Lazić,
Hristina Čolović, 
Olga Marinković, 
Marija Spalević,
AnitaStanković 
and Dragan Zlatanović 
 

 

Autoren-Details:
Department of Physical Medicine, Rehabilitation andProsthetics, Clinical Center Niš
Contact: Ljiljana Lazić
Department of Physical Medicine, Rehabilitation andProsthetics, Clinical Centre Niš
Blvd. Zoran Đinđić 48, 18 000 Niš
E-mail: draganzlatanovic1@gmail.com